1
TÍTULO: Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines  Full Text
AUTORES: Falk Ehmann; Kumiko Sakai Kato; Ruth Duncan; Dolores Hernan Perez de la Ossa; Ruben Pita; Jean Marc Vidal; Ashish Kohli; Laszlo Tothfalusi; Alan Sanh; Sandrine Tinton; Jean Louis Robert; Beatriz Silva Lima ; Marisa Papaluca Amati;
PUBLICAÇÃO: 2013, FONTE: NANOMEDICINE, VOLUME: 8, NÚMERO: 5
INDEXADO EM: Scopus WOS CrossRef: 59
2
TÍTULO: Juvenile Animal Studies for the Development of Paediatric Medicines: A Description and Conclusions From a European Medicines Agency Workshop on Juvenile Animal Testing for Nonclinical Assessors  Full Text
AUTORES: Beatriz Silva Lima ; Mette Due Theilade Thomsen; Jacqueline Carleer; Jean Marc Vidal; Paolo Tomasi; Agnes Saint Raymond;
PUBLICAÇÃO: 2010, FONTE: BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, VOLUME: 89, NÚMERO: 6
INDEXADO EM: Scopus WOS
3
TÍTULO: Towards consensus practices to qualify safety biomarkers for use in early drug development  Full Text
AUTORES: Frank D Sistare; Frank Dieterle; Sean Troth; Daniel J Holder; David Gerhold; Dina Andrews Cleavenger; William Baer; Graham Betton; Denise Bounous; Kevin Carl; Nathaniel Collins; Peter Goering; Federico Goodsaid; Yi Zhong Gu; Valerie Guilpin; Ernie Harpur; Alita Hassan; David Jacobson Kram; Peter Kasper; David Laurie; Beatriz Silva Lima ; Romaldas Maciulaitis; William Mattes; Gerard Maurer; Leslie Ann Obert; Josef Ozer; Marisa Papaluca Amati; Jonathan A Phillips; Mark Pinches; Matthew J Schipper; Karol L Thompson; Spiros Vamvakas; Jean Marc Vidal; Jacky Vonderscher; Elizabeth Walker; Craig Webb; Yan Yu; ...Mais
PUBLICAÇÃO: 2010, FONTE: NATURE BIOTECHNOLOGY, VOLUME: 28, NÚMERO: 5
INDEXADO EM: Scopus WOS CrossRef: 70